Our Services
We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.
Investment Banking
Equity Research
Capital Markets
Merchant Capital
Wealth Management
Prime Brokerage
Recent
Transactions
Over 180 financings and $23.5 Billion in aggregate as Lead, Joint, or Co-Manager in 2021
$555.0 Million
Business Combination
// Sole Underwriter for AGBA
November 2022
Up to $30 Million
Private Placement
// Exclusive Placement Agent
November 2022
$16.7 Million
Follow-On Offering
// Sole Book-Running Manager
October 2022
SPAC Business Combination
// Financial Advisor to SeaStar Medical
October 2022
$15.0 Million
Registered Direct Offering
// Sole Placement Agent
October 2022
$2.0 Million
Follow-On Offering
// Exclusive Placement Agent
October 2022
$60.0 Million
Initial Public Offering
// Sole Book-Running Manager
October 2022
$4.7 Million
Fully Marketed Rights Offering
// Dealer-Manager
October 2022
$650.0 Million
Definitive Business Combination Agreement
// Financial Advisor to ClimateRock
October 2022
$4.0 Million
Registered Direct Offering
// Sole Placement Agent
October 2022
$4.8 Million
Warrant Inducement Transaction
// Warrant Inducement Agent and Financial Advisor
October 2022
Upcoming Events
Maxim Group events are hosted on our digital platform, M-Vest
There are no upcoming events at this time
![Maxim_Merchant-Capital_logo-01[1]](https://www.maximgrp.com/wp-content/uploads/2020/02/Maxim_Merchant-Capital_logo-011.svg "Maxim_Merchant-Capital_logo-01[1]"){kind=logo}
Merchant Capital
Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.
